369 Clinical update of VT1021, a first-in-class CD36 and CD47 targeting immunomodulating agent, in subjects with pancreatic cancer and other solid tumors stratified by novel biomarkers
oleh: Afshin Dowlati, Andrea Bullock, Susanna Ulahannan, Manish Patel, Shubham Pant, Marsha Crochiere, Jian Chen, Devalingam Mahalingam, Mary Mulcahy, Lou Vaickus, Suming Wang, Melanie Vincent, Michael Cieslewicz, Jing Watnick, Dejan Juric, Susanne Fyfe, Randolph Watnick
| Format: | Article |
|---|---|
| Diterbitkan: | BMJ Publishing Group 2021-11-01 |
Deskripsi
No description available for this item.